Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
1082 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-07-24)
Due Date
July 24, 2028
Grace Period Ends
January 24, 2029
Application History
38 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 16, 2025 | 8.PR | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | Loading... |
Jun 16, 2025 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
Mar 13, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Jul 19, 2024 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
Jul 24, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
Oct 11, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 11, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Oct 11, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Oct 11, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 11, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Oct 11, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Dec 17, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Dec 17, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jul 24, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jun 15, 2018 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
Jun 15, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
May 18, 2018 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
May 18, 2018 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
Nov 21, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 17, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Nov 17, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Nov 17, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 23, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 28, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 28, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 8, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 22, 2017 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 13, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 9, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 9, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 2, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 17, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 27, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 27, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 27, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 21, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 20, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Sep 19, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
[ Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; cell cultures and media, namely, biological preparations for use in cell cultures other than for medical and veterinary use; cell growth media for growing cells for use in scientific research; cell media for growing cells for use in scientific research, namely, for use in the production of pharmaceuticals, vaccines, monoclonal antibodies and recombinant proteins; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant compliment compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific purposes and for use in industry; chemical preparations, namely, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology in the nature of reagents for use in the preparation of invitro diagnostic kits; chemical preparations, namely, monoclonal antibodies for use in invitro scientific or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells; diagnostic and testing agents for scientific or research use, namely, reagents for use in anti-body screening, blood grouping and the typing and detecting of specific blood cells; diagnostic reagents and preparations except for medical or veterinary use ]
Class 005
Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, influenza, respiratory disease and disorders; pharmaceutical preparations and substances for the treatment and/or prevention of stroke or heart failure; vaccines; anti-virals; antigens for medical purposes; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; [ test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]
Classification
International Classes
001
005